Long-Term Outcomes After Implantation of Magnesium-Based Bioresorbable Scaffolds—Insights From an All-Comer Registry
BackgroundThe magnesium-based sirolimus-eluting bioresorbable scaffold (Mg-BRS) Magmaris™ showed promising clinical outcomes, including low rates of both the target lesion failure (TLF) and scaffold thrombosis (ScT), in selected study patients. However, insights regarding long-term outcomes (>...
Main Authors: | Matthias Bossard, Mehdi Madanchi, Dardan Avdijaj, Adrian Attinger-Toller, Giacomo Maria Cioffi, Thomas Seiler, Gregorio Tersalvi, Richard Kobza, Guido Schüpfer, Florim Cuculi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.856930/full |
Similar Items
-
Sex Differences in the Clinical Features and Outcomes of Patients with Acute Coronary Syndrome Treated with Two Generations (Absorb and Magmaris) of Bioresorbable Vascular Scaffolds
by: Adrian Włodarczak, et al.
Published: (2021-08-01) -
Long-term (> 12 months) single-center registry of Magmaris implantation in the acute coronary syndrome setting
by: Jeremías Bayón, et al.
Published: (2021-11-01) -
Bioresorbable scaffold -fourth revolution or failed revolution: Is low scaffold strut thickness the wrong target?
by: Sundeep Mishra
Published: (2017-11-01) -
Acute Mechanical Performance of Magmaris vs. DESolve Bioresorbable Scaffolds in a Real-World Scenario
by: Niklas F. Boeder, et al.
Published: (2021-06-01) -
Bioresorbable vascular scaffolds technology: current use and future developments
by: Giacchi G, et al.
Published: (2016-07-01)